Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001717888 | SCV001942037 | benign | not provided | 2020-08-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002073348 | SCV002407675 | benign | CHARGE syndrome | 2024-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002359222 | SCV002654828 | likely benign | Inborn genetic diseases | 2021-10-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003968510 | SCV004781010 | likely benign | CHD7-related disorder | 2023-11-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |